Eric Schmidt

Work Performance Price Targets & Ratings Chart

Analyst Eric Schmidt, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 45% that have a potential upside of 26.75% achieved within 818 days.

Eric Schmidt’s has documented 54 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on RNA, Avidity Biosciences at 16-Sep-2024.

Wall Street Analyst Eric Schmidt

Analyst best performing recommendations are on BIIB (BIOGEN).
The best stock recommendation documented was for BIIB (BIOGEN) at 1/2/2018. The price target of $338 was fulfilled within 1 day with a profit of $3.83 (1.15%) receiving and performance score of 11.46.

Average potential price target upside

of $68.61 (51.72%) on AMGN (AMGEN).
of $52.11 (41.69%) on ALXN (ALEXION PHARMACEUTICALS).
of $49.92 (16.55%) on BIIB (BIOGEN).

BIIB Biogen CELG Celgene INCY yte AMGN Amgen ALXN Alexion Pharmaceuticals BLUE Bluebird bio AGIO Agios Pharm CRSP Crispr Therapeutics AG IMCR Immunocore Holdings Ltd IMTX Immatics NV RNA Avidity Biosciences TNGX Tango Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Christopher Raymond (PIPER SANDLER)